SIRT3 and diffuse large B-cell lymphoma: To compensate for this loss, DLBCL cells divert glucose utilization from glycolysis (decreased lactate and 3-phosphoglyceric acid) and biosynthesis (decreased serine biosynthesis) to the TCA cycle, which is still not sufficient to rescue DLBCL cells from SIRT3 loss of function (9).